Evidence map›Paper›PMID 40821938›Full record

ArticleFrontiers in nephrology2025

Kidney transplantation between identical twins with APOL1 homozygote risk alleles - a case report.

Sean Lei, Abhirami Shankar, Supreet Sethi, Erik L Lum

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sean LeiDivision of Nephrology, Department of Medicine, David Geffen School of Medicine - University of California, Los Angeles, CA, United States.
Abhirami ShankarDivision of Nephrology, Harbor University of California Los Angeles Medical Center, Los Angeles, CA, United States.
Supreet SethiDivision of Nephrology, Department of Medicine, David Geffen School of Medicine - University of California, Los Angeles, CA, United States.
Erik L LumDivision of Nephrology, Department of Medicine, David Geffen School of Medicine - University of California, Los Angeles, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney transplantation is the optimal therapy for individuals with end-stage kidney disease. Recent studies suggest a negative impact of high-risk Apolipoprotein L1 genotypes on outcomes for both living kidney donors and kidney transplant recipients. In this case, we describe a pair of identical twins with a high-risk APOL1 genotype who underwent successful living kidney transplantation with excellent short-term outcomes.

Indexed as

APO L1genetic kidney diseasekidney transplantkidney transplantationliving donor

Identifiers

PMID40821938
PMCPMC12350138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.